IP Library Granted Patent US 7,608,291
Granted Patent B2
US 7,608,291 · App. 10/221,423 · Granted Oct 27, 2009

Treatment of infection in animals

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,608,291
App. No.
10/221,423
Granted
Oct 27, 2009
Kind
B2
Abstract

The present invention relates to the use of a non-digestible carbohydrate in the manufacture of a composition for treating or preventing pathogenic bacteria in the large intestine of a pet animal. It also provides a method for the prevention or treatment of a pathogenic bacteria in the large intestine of a pet animal, the method comprising administering to said pet animal a composition which comprises a non-digestible carbohydrate.

Claims (9)

1. A method for treating a pathogenic Campylobacter, Escherichia coli or Salmonella bacteria in a large intestine of a dog or cat, the method comprising the step of administering to the dog or cat a pet food product comprising of a non-digestible carbohydrate which is,

a) a dietary fiber source selected from the group consisting of coconut endosperm fiber, beet pulp, citrus pulp, rice bran, carob bean or gum talha and combinations thereof, and/or

b) an oligosaccharide selected from the group consisting of galactooligosaccharide, maltooligosaccharide, xylooligosaccharide, raffinose and combinations thereof,

wherein the pet food product is administered to deliver the non-digestible carbohydrate of a) and/or b), in an amount sufficient to treat the pathogenic Campylobacter, Escherichia coli or Salmonella bacteria in the large intestine of the dog or cat.

2. The method of claim 1 , wherein the pathogenic bacteria is Campylobacter jejuni or Salmonella enterica.

3. The method of 1 , wherein the pathogenic bacteria is Campylobacter jejuni and the non-digestible carbohydrate comprises a galactooligosaccharide.

4. The method of claim 1 , wherein the pathogenic bacteria is Salmonella enterica Serotype Typhimurium and the non-digestible carbohydrate comprises a galactooligosaccharide.

5. The method of claim 3 or 4 wherein the pet food is administered in an amount sufficient to cause a decrease in intestinal pH thereby treating the pathogenic bacteria.

6. The method of claim 1 , wherein the pathogenic bacteria is Campylobacter jejuni and the non-digestible carbohydrate comprises a coconut endosperm fiber.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2009
From: MARS U.K.
To: MARS, INCORPORATED
Reel/Frame 022581/0069 →
CHANGE OF NAME Recorded Apr 17, 2009
From: MARS U.K. LIMITED
To: MARS U.K.
Reel/Frame 022563/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2003
From: BAILLON, MARIE-LOUISE; GIFFARD, CATRIONA J.
To: MARS UK LIMITED
Reel/Frame 014084/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2003
From: MARS UK LIMITED
To: MARS INCORPORATED
Reel/Frame 014084/0424 →